Published in Vaccine on March 01, 1985
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun (1993) 3.04
Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun (1993) 2.36
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect Immun (1998) 2.02
Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun (1996) 1.61
Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect Immun (1992) 1.52
Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun (1996) 1.33
Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect Immun (1990) 1.25
Pertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. Infect Immun (1990) 1.19
Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect Immun (2000) 1.17
Proliferative responses and gamma interferon and tumor necrosis factor production by lymphocytes isolated from tracheobroncheal lymph nodes and spleen of mice aerosol infected with Bordetella pertussis. Infect Immun (1992) 1.16
Targeted mutations that ablate either the adenylate cyclase or hemolysin function of the bifunctional cyaA toxin of Bordetella pertussis abolish virulence. Proc Natl Acad Sci U S A (1992) 1.15
Mapping of linear B-cell epitopes of the S2 subunit of pertussis toxin. Infect Immun (1989) 1.13
Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol (2004) 1.10
Specific lung mucosal and systemic immune responses after oral immunization of mice with Salmonella typhimurium aroA, Salmonella typhi Ty21a, and invasive Escherichia coli expressing recombinant pertussis toxin S1 subunit. Infect Immun (1992) 1.09
Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping. Infect Immun (1989) 1.05
Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit. Infect Immun (1989) 1.04
Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Proc Natl Acad Sci U S A (1989) 1.03
Expression of pertussis toxin in Bordetella bronchiseptica and Bordetella parapertussis carrying recombinant plasmids. Infect Immun (1989) 1.00
Bordetella pertussis autoregulates pertussis toxin production through the metabolism of cysteine. Infect Immun (2001) 0.95
Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model. Infect Immun (2006) 0.90
Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica. Infect Immun (1991) 0.90
Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals. Infect Immun (1991) 0.88
Direct expression of Bordetella pertussis filamentous hemagglutinin in Escherichia coli and Salmonella typhimurium aroA. Infect Immun (1991) 0.87
Characterization of murine monoclonal antibodies that recognize defined epitopes of pertussis toxin and neutralize its toxic effect on Chinese hamster ovary cells. Infect Immun (1991) 0.87
Antigenic divergence of Bordetella pertussis isolates in Taiwan. J Clin Microbiol (2005) 0.83
Identification of human T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1992) 0.82
Expression of a C terminally truncated form of pertussis toxin S1 subunit effectively induces protection against pertussis toxin following DNA-based immunization. Infect Immun (2004) 0.76
Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran. Int J Mol Cell Med (2015) 0.75
Immunogenicity of specific Bordetella pertussis surface antigens in diphtheria-tetanus-pertussis (DTP) vaccines. Epidemiol Infect (1988) 0.75
Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet (2001) 63.36
One-stop shop for microarray data. Nature (2000) 13.54
Papers and originals. Br Med J (1976) 5.90
Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ (1997) 5.29
Accessing and distributing EMBL data using CORBA (common object request broker architecture). Genome Biol (2000) 4.26
IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res (1998) 3.74
Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3, and 4 months versus 3, 5, and 9 months of age. Lancet (1992) 3.60
Home screening for chlamydial genital infection: is it acceptable to young men and women? Sex Transm Infect (2000) 3.46
Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP Research Group. Lancet (2001) 2.79
Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler (2011) 2.77
Genitourinary medicine services in the United Kingdom are failing to meet current demand. Int J STD AIDS (2001) 2.47
Antigenic relationship between serotype-specific agglutinogen and fimbriae of Bordetella pertussis. Infect Immun (1982) 2.28
Cloning and nucleotide sequence analysis of the serotype 2 fimbrial subunit gene of Bordetella pertussis. Mol Microbiol (1987) 2.23
Isolation of the lymphocytosis promoting factor-haemagglutinin of Bordetella pertussis by affinity chromatography. Biochim Biophys Acta (1979) 2.22
Sex chromosome tetrasomy and pentasomy. Pediatrics (1995) 2.19
A new improved sub-unit vaccine for plague: the basis of protection. FEMS Immunol Med Microbiol (1995) 2.16
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet (2000) 2.08
Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease. The PARI-IS Study Steering Committee and Research Group. Prevention of Acute Respiratory Infection by an Immunostimulant. Am J Respir Crit Care Med (1997) 2.04
Side effects of hyperbaric oxygen therapy in children with cerebral palsy. Undersea Hyperb Med (2006) 2.03
Quality evaluation of sputum specimens for mycobacterial culture. Am J Clin Pathol (1996) 1.89
Science journal editors' views on publication ethics: results of an international survey. J Med Ethics (2009) 1.88
Plasma membranes: phospholipid and sterol content. Science (1966) 1.87
Factors associated with non-adherence to oral medication for inflammatory bowel disease: a systematic review. Am J Gastroenterol (2009) 1.84
Protection against intranasal infection of mice with Bordetella pertussis. Dev Biol Stand (1985) 1.84
Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory. J Clin Microbiol (1993) 1.82
Recessive sex-linked mental retardation in the absence of other recognizable abnormalities. Report of a family. Clin Pediatr (Phila) (1969) 1.77
Mining for putative regulatory elements in the yeast genome using gene expression data. Proc Int Conf Intell Syst Mol Biol (2000) 1.73
Maintenance of some ColE1-type plasmids in chemostat culture. Mol Gen Genet (1980) 1.68
Three-generation pedigree of a Möbius syndrome variant with chromosome translocation. Arch Neurol (1977) 1.65
Screening for sexually transmitted infections in children and adolescents in the United Kingdom: British Co-operative Clinical Group. Int J STD AIDS (2001) 1.61
Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol (1998) 1.59
Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ (1991) 1.57
Sexually transmitted diseases in rape victims. Genitourin Med (1990) 1.56
Familial myeloproliferative disease. A new syndrome closely simulating myelogenous leukemia in childhood. Am J Dis Child (1965) 1.55
A limit theorem on the cores of large standard exchange economies. Proc Natl Acad Sci U S A (1972) 1.54
Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. J Hyg (Lond) (1982) 1.51
Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection. Infect Immun (2001) 1.51
Immune responses in humans and animals to meningococcal transferrin-binding proteins: implications for vaccine design. Infect Immun (1994) 1.51
National guideline for the management of suspected sexually transmitted infections in children and young people. Sex Transm Infect (2002) 1.51
Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice. Infect Immun (1983) 1.50
Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies. J Gen Microbiol (1983) 1.49
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis (1995) 1.48
Studies on chromosomal nondisjunction in man. II. Am J Hum Genet (1967) 1.48
The occurrence of carcinoma of the pancreas in chronic pancreatitis. Radiology (1970) 1.46
Analysis of non-disjunction in sex chromosome tetrasomy and pentasomy. Hum Genet (1990) 1.44
Studies on chromosomal nondisjunction in man. 3. Am J Hum Genet (1969) 1.43
Chlamydia screening in the United Kingdom. Sex Transm Infect (2003) 1.42
THE SOMATIC CHROMOSOMAL CONSTITUTION OF SOME HUMAN SUBJECTS WITH GENETIC DEFECTS. Proc Natl Acad Sci U S A (1959) 1.42
Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG (2000) 1.42
Construction and characterization of Bordetella pertussis mutants lacking the vir-regulated P.69 outer membrane protein. Mol Microbiol (1991) 1.42
Release and purification of fimbriae from Bordetella pertussis. Dev Biol Stand (1985) 1.41
Non-random occurrence of 7-14 translocations in human lymphocyte cultures. Nature (1975) 1.41
Efficacy of bomb shelters: with lessons from the Hamburg firestorm. South Med J (1990) 1.40
The white coat effect in hypertensive pregnancy: much ado about nothing? Br J Obstet Gynaecol (1999) 1.40
Separation of Legionella pneumophila proteases and purification of a protease which produces lesions like those of Legionnaires' disease in guinea pig lung. J Gen Microbiol (1986) 1.39
Raised cardiac troponin T levels in patients without acute coronary syndrome. Postgrad Med J (2007) 1.39
On a Specimen of the Hind-gut opening into a Cloacal Chamber in a Child. J Anat Physiol (1906) 1.39
Quality-of-life measurements can play key role in determining treatment, MD says. CMAJ (1994) 1.39
Isotypes of spontaneous and mitogen-induced autoantibodies in SLE-prone mice. J Immunol (1984) 1.39
The signal sequence of the p62 protein of Semliki Forest virus is involved in initiation but not in completing chain translocation. J Cell Biol (1990) 1.38
Trends in attendances to genitourinary medicine services by older women. Int J STD AIDS (2012) 1.38
Lymphoproliferative responses in macaques immunized with inactivated SIV vaccine. AIDS Res Hum Retroviruses (1993) 1.38
Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health (2000) 1.37
Sickle cell disease, the thalassemias, Tay-Sachs disease: protein to gene. CMAJ (1993) 1.37
Analysis of muscle creatine kinase regulatory elements in recombinant adenoviral vectors. Mol Ther (2000) 1.36
Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Res Hum Retroviruses (1993) 1.34
Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb Pathog (1993) 1.34
THE HUMAN CHROMOSOMAL SATELLITES IN NORMAL PERSONS AND IN TWO PATIENTS WITH MARFAN'S SYNDROME. Proc Natl Acad Sci U S A (1960) 1.32
Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens. Lancet (1991) 1.32
Pulmonary damage caused by a protease from Legionella pneumophila. Br J Exp Pathol (1986) 1.29
Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance. Vaccine (1997) 1.29
Adverse events and antibody response to accelerated immunisation in term and preterm infants. Arch Dis Child (1995) 1.28
Absent IgA and deletions of chromosome 18. J Med Genet (1970) 1.26
Project MICAS--medical information, communication and archive system: PACS implementation at the University of Rochester Medical Center. J Digit Imaging (1997) 1.25
Transcendental meditation in hypertension. Individual response patterns. Lancet (1976) 1.24
Cord formation in BACTEC medium is a reliable, rapid method for presumptive identification of Mycobacterium tuberculosis complex. J Clin Microbiol (1998) 1.24
Structure and biological properties of solubilized envelope proteins of Bordetella pertussis. Infect Immun (1983) 1.24
Enhanced antenatal detection of group B streptococcus colonization. Obstet Gynecol (1995) 1.23
Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project. Health Technol Assess (2010) 1.22
Growth and siderophore production by Bordetella pertussis under iron-restricted conditions. FEMS Microbiol Lett (1990) 1.22
Screening of newborn infants for abnormalities of the Y chromosome. J Pediatr (1971) 1.21
Cytology of rheumatoid synovial cells in culture. I. Composition and sequence of cell populations in cultures of rheumatoid synovial fluid. Ann Rheum Dis (1974) 1.21
Tetraploidy in cells cultured from amniotic fluid. Lancet (1970) 1.21
Exercise testing revisited. The response to exercise in normal and atopic children. Chest (1994) 1.21
Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential. Vaccine (1995) 1.21
Lectures on the Early Stages in the Development of Mammalian Ova and on the Differentiation of the Placenta in Different Groups of Mammals: Lecture II. J Anat Physiol (1904) 1.19